WntResearch AB (NGM: WNT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.664
-0.006 (-0.90%)
At close: Jan 24, 2025
-89.94%
Market Cap 5.91M
Revenue (ttm) n/a
Net Income (ttm) -44.02M
Shares Out 8.66M
EPS (ttm) -6.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,288
Average Volume 29,517
Open 0.622
Previous Close 0.670
Day's Range 0.622 - 0.736
52-Week Range 0.600 - 17.200
Beta 0.57
RSI 47.51
Earnings Date Feb 7, 2025

About WntResearch AB

WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden. [Read more]

Industry Other
Founded 2007
Employees 2
Stock Exchange Nordic Growth Market
Ticker Symbol WNT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.